Antimicrobial Agents and Chemotherapy · 2018 · 45 citations · 33 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceDrug DiscoveryMedical MicrobiologyAntibacterial AgentsAntibacterial PharmacologyAntibacterial ResistanceAntibacterial TherapyAntibiotic ResistanceDrug-susceptible Tuberculosis TreatmentAntibacterial PropertiesBacteriocin-mediated InteractionsFirst-line Antituberculosis TherapyMultidrug-resistant Tuberculosis TreatmentMycobacterium Tuberculosis InfectionNontuberculous Mycobacterial InfectionsTuberculosis Drug DevelopmentTuberculosis Drug Resistance
The increasing incidence of multidrug-resistant Mycobacterium tuberculosis strains and the very few drugs available for treatment are promoting the discovery and development of new molecules that could help in the control of this disease. Bacteriocin AS-48 is an antibacterial peptide produced by Enterococcus faecalis and is active against several Gram-positive bacteria.
33
Global tuberculosis report (2014)
L.A. Gabbasova, E.R. Experts Who · 2014 · 13.2K citations
Juan-Carlos Palomino, Anandi Martin, Mirtha Camacho et al. · Antimicrobial Agents and Chemotherapy · 2002 · 1.2K citations · Full text